Results 121 to 130 of about 20,495 (161)

Clinical pharmacology of sulfonylureas

Metabolism, 1987
Sulfonylureas seem to have similar mechanisms of action, including an acceleration and increase of insulin secretion, an increase of the systemic availability of insulin, and probably indirectly, an increase of insulin action. Sulfonylureas may postpone the development of impaired glucose tolerance (IGT) to manifest non-insulin-dependent diabetes ...
openaire   +2 more sources

Sulfonylureas

Reactions Weekly, 1993
openaire   +6 more sources

Hyponatremia and Sulfonylureas

Diabetes Care, 1984
openaire   +2 more sources

Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta‐analysis

Diabetes Research and Clinical Practice, 2020
Zhen Zhang, Yang Cao
exaly  

Sulfonylureas

2006
  +4 more sources

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

Diabetes Care, 2004
John Buse, Jenny Han, Buse John B
exaly  

Sulfonylureas

2007
openaire   +1 more source

Sulfonylurea KATPBlockade in Type II Diabetes and Preconditioning in Cardiovascular Disease

Circulation, 1996
, R L Engler
exaly  

Intrapancreatic Infusions of the Sulfonylureas

Diabetes, 1957
A R, COLWELL, J A, COLWELL
openaire   +2 more sources

Sulfonylureas

Reactions Weekly, 1995
openaire   +3 more sources